Login / Signup

Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm-like pain: A randomized, double-blinded, multicenter Phase III trial.

Chun Ping ZhuFei JiangRong Quan WangXiao Zhong GuoXiao Hua HouHong XuYa ZengYi-Qi DuZhao Shen Li
Published in: Journal of digestive diseases (2018)
HBB 20 mg was not inferior to anisodamine 10 mg in pain relief of patients with acute gastric or intestinal spasm-like pain. Both drugs were safe and well tolerated.
Keyphrases
  • phase iii
  • chronic pain
  • pain management
  • neuropathic pain
  • clinical trial
  • open label
  • double blind
  • phase ii
  • study protocol
  • liver failure
  • drug induced
  • cross sectional
  • placebo controlled
  • randomized controlled trial